swish30

** ONCS dip buy for potential running upside on clinical data

Long
NASDAQ:ONCS   None
Usually clinical data isn't super positive on day 2 but these guys recently raised money, Point72 bought into the company. Almost no shares to short out there.

Today I expect this to trade around 2.15 in decent size. Looking to buy on dips for instant profit and potentially hold some for a run up to $3

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.